Literature DB >> 17295049

Iron acquisition mechanisms of the Burkholderia cepacia complex.

Mark S Thomas1.   

Abstract

The Burkholderia cepacia complex (Bcc) is comprised of at least 10 closely related species of Gram-negative proteobacteria that are associated with infections in certain groups of immunocompromised individuals, particularly those with cystic fibrosis. Infections in humans tend to occur in the lungs, which present an iron-restricted environment to a prospective pathogen, and accordingly members of the Bcc appear to possess efficient mechanisms for iron capture. These bacteria specify up to four different types of siderophore (ornibactin, pyochelin, cepabactin and cepaciachelin) that employ the full repertoire of iron-binding groups present in most naturally occurring siderophores. Members of the Bcc are also capable of utilising some exogenous siderophores that they are not able to synthesise. In addition to siderophore-mediated mechanisms of iron uptake, the Bcc possess mechanisms for acquiring iron from haem and from ferritin. The Bcc therefore appear to be well-equipped for life in an iron-poor environment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295049     DOI: 10.1007/s10534-006-9065-4

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  21 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

Authors:  Elizabeth J Summer; Jason J Gill; Chris Upton; Carlos F Gonzalez; Ry Young
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

3.  Potential of Burkholderia seminalis TC3.4.2R3 as Biocontrol Agent Against Fusarium oxysporum Evaluated by Mass Spectrometry Imaging.

Authors:  Francisca Diana da Silva Araújo; Welington Luiz Araújo; Marcos Nogueira Eberlin
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-13       Impact factor: 3.109

Review 4.  Nonribosomal peptides and polyketides of Burkholderia: new compounds potentially implicated in biocontrol and pharmaceuticals.

Authors:  Qassim Esmaeel; Maude Pupin; Philippe Jacques; Valérie Leclère
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-25       Impact factor: 4.223

5.  The Small Protein HemP Is a Transcriptional Activator for the Hemin Uptake Operon in Burkholderia multivorans ATCC 17616.

Authors:  Takuya Sato; Shouta Nonoyama; Akane Kimura; Yuji Nagata; Yoshiyuki Ohtsubo; Masataka Tsuda
Journal:  Appl Environ Microbiol       Date:  2017-08-01       Impact factor: 4.792

6.  Synthesis and iron sequestration equilibria of novel exocyclic 3-hydroxy-2-pyridinone donor group siderophore mimics.

Authors:  James M Harrington; Sumathi Chittamuru; Suraj Dhungana; Hollie K Jacobs; Aravamudan S Gopalan; Alvin L Crumbliss
Journal:  Inorg Chem       Date:  2010-09-20       Impact factor: 5.165

7.  Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite.

Authors:  Elke Peeters; Andrea Sass; Eshwar Mahenthiralingam; Hans Nelis; Tom Coenye
Journal:  BMC Genomics       Date:  2010-02-05       Impact factor: 3.969

Review 8.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

9.  Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants.

Authors:  Sílvia A Sousa; Christian G Ramos; Jorge H Leitão
Journal:  Int J Microbiol       Date:  2010-08-03

10.  Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.

Authors:  Brian H Kvitko; Andrew Goodyear; Katie L Propst; Steven W Dow; Herbert P Schweizer
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.